How Recent Advances in High-risk Myelodysplastic Syndrome Physiopathology May Impact Future Treatments

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|30|5362-5373

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.30, 2013-09, pp. : 5362-5373

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact of Abciximab in Elderly Patients with High-Risk Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Observational Registry Study

By Iversen Allan Z.   Galatius Soeren   Pedersen Sune   Madsen Jan K.   Jensen Jan S.  

Drugs & Aging, Vol. 28, Iss. 5, 2011-05 ,pp. : 369-378

Adis International

Access to resources Recommend Favorite

Emerging Treatments and Gene Expression Profiling in High-Risk Medulloblastoma

By Sardi Iacopo  

Pediatric Drugs, Vol. 9, Iss. 2, 2007-01 ,pp. : 81-96

Adis International

Access to resources Recommend Favorite

Characteristics of High-Risk HIV-Positive IDUs in Vietnam: Implications for Future Interventions

By Go Vivian F.   Frangakis Constantine   Nam Le Van   Sripaipan Teerada   Bergenstrom Anna   Li Fan   Latkin Carl   Celentano David D.   Quan Vu Minh  

Substance Use & Misuse, Vol. 46, Iss. 4, 2011-02 ,pp. : 381-389

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in Combination Treatments for Photoaging: Review of the Literature

By TIERNEY EMILY P.   HANKE C. WILLIAM  

Dermatologic Surgery, Vol. 36, Iss. 6, 2010-06 ,pp. : 829-840

Elsevier

Access to resources Recommend Favorite

Recent Advances in Anti-Survivin Treatments for Cancer

By  

Current Medicinal Chemistry, Vol. 17, Iss. 15, 2010-05 ,pp. : 1509-1515

Bentham Science Publishers

Access to resources Recommend Favorite